Bioequivalence for Parenteral Products [Regulatives / Guidelines]

posted by arailkar – 2020-05-29 19:21 (1689 d 10:53 ago) – Posting: # 21491
Views: 2,227

Dear Helmut,

I am interested in finding out if bioequivalence study is needed in the US when an IV formulation is changed to a subcutaneous formulation. I would also appreciate if you can please give me references to US FDA Guidance document that addresses this topic. Thank you very much.

Regards,
Ani

Complete thread:

UA Flag
Activity
 Admin contact
23,359 posts in 4,905 threads, 1,672 registered users;
94 visitors (0 registered, 94 guests [including 14 identified bots]).
Forum time: 05:14 CET (Europe/Vienna)

You are rewarding a teacher poorly
if you remain always a pupil.    Friedrich Nietzsche

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5